Number of the records: 1  

Extracellular polysaccharide produced by Chlorella vulgaris - Chemical characterization and anti-asthmatic profile

  1. 1.
    SYSNO ASEP0517850
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleExtracellular polysaccharide produced by Chlorella vulgaris - Chemical characterization and anti-asthmatic profile
    Author(s) Barboríková, J. (SK)
    Šutovská, M. (SK)
    Kazimierová, I. (SK)
    Jošková, M. (SK)
    Frantová, S. (SK)
    Kopecký, Jiří (MBU-M) ORCID
    Čapek, P. (SK)
    Source TitleInternational Journal of Biological Macromolecules. - : Elsevier - ISSN 0141-8130
    Roč. 135, AUG 15 2019 (2019), s. 1-11
    Number of pages11 s.
    Languageeng - English
    CountryNL - Netherlands
    KeywordsGreen microalgae ; Extracellular polysaccharide ; Anti-asthmatic effect
    Subject RIVCE - Biochemistry
    OECD categoryBiochemistry and molecular biology
    Method of publishingLimited access
    Institutional supportMBU-M - RVO:61388971
    UT WOS000477691600001
    EID SCOPUS85066030442
    DOI10.1016/j.ijbiomac.2019.05.104
    AnnotationMicroalgae are the lowest plant organisms producing a wide range of metabolites that make them interesting organisms for industrial applications. Cultivation of green microalgal species Chlorella vulgaris resulted a significant production of extracellular polysaccharide (EPS). Preliminary chemico-spectroscopic studies on EPS revealed its molecular profile, a complex primary structure consisting of six monosaccharide units occurring in both furano and pyrano forms, a high sugar binding variability and the presence of partially methylated derivatives of some sugar constituents. Biological activity tests showed that EPS caused significant bronchodilatory, anti-inflammatory and antitussive effects in test animals. Chlorella EPS appears to be a promising agent for the prevention of chronic airway inflammation, which is the basic pathogenic mechanism of many respiratory diseases, including bronchial asthma.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2020
    Electronic addresshttps://www.jbc.org/content/294/29/11131
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.